These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 26823761

  • 21. [Silencing pyruvate kinase M2 sensitizes human prostate cancer PC3 cells to gambogic acid-induced apoptosis].
    Lü L, Wang L, Jiang GS, Zhang CH, Zeng FQ.
    Zhonghua Nan Ke Xue; 2013 Feb; 19(2):102-6. PubMed ID: 23441447
    [Abstract] [Full Text] [Related]

  • 22. Gene Regulatory Effect of Pyruvate Kinase M2 is Involved in Renal Inflammation in Type 2 Diabetic Nephropathy.
    Li L, Tang L, Yang X, Chen R, Zhang Z, Leng Y, Chen AF.
    Exp Clin Endocrinol Diabetes; 2020 Sep; 128(9):599-606. PubMed ID: 31958846
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Wnt4 antagonises Wnt3a mediated increases in growth and glucose stimulated insulin secretion in the pancreatic beta-cell line, INS-1.
    Bowen A, Kos K, Whatmore J, Richardson S, Welters HJ.
    Biochem Biophys Res Commun; 2016 Oct 28; 479(4):793-799. PubMed ID: 27687546
    [Abstract] [Full Text] [Related]

  • 25. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
    Kachel P, Trojanowicz B, Sekulla C, Prenzel H, Dralle H, Hoang-Vu C.
    BMC Cancer; 2015 Mar 18; 15():140. PubMed ID: 25880801
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S, Miyata H, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.
    Ann Surg Oncol; 2015 Dec 18; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [Abstract] [Full Text] [Related]

  • 28. Histone deacetylase regulates insulin signaling via two pathways in pancreatic β cells.
    Kawada Y, Asahara SI, Sugiura Y, Sato A, Furubayashi A, Kawamura M, Bartolome A, Terashi-Suzuki E, Takai T, Kanno A, Koyanagi-Kimura M, Matsuda T, Hashimoto N, Kido Y.
    PLoS One; 2017 Dec 18; 12(9):e0184435. PubMed ID: 28886131
    [Abstract] [Full Text] [Related]

  • 29. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W, Wang Y, Chen X, Shi Y, Wang J, Zhang J, Qian J, Li R, Tao T, Wei W, Hu Q, Liu N, You Y.
    Oncotarget; 2015 May 30; 6(15):13006-18. PubMed ID: 25948776
    [Abstract] [Full Text] [Related]

  • 30. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M, Tanuma N, Shibuya R, Shiroki T, Abue M, Yamamoto K, Miura K, Yamaguchi K, Sato I, Tamai K, Satoh K.
    Int J Oncol; 2018 Mar 30; 52(3):881-891. PubMed ID: 29393401
    [Abstract] [Full Text] [Related]

  • 31. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose.
    Li X, Deng S, Liu M, Jin Y, Zhu S, Deng S, Chen J, He C, Qin Q, Wang C, Zhao G.
    Cell Death Dis; 2018 Jan 26; 9(2):133. PubMed ID: 29374159
    [Abstract] [Full Text] [Related]

  • 32. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
    Dey P, Son JY, Kundu A, Kim KS, Lee Y, Yoon K, Yoon S, Lee BM, Nam KT, Kim HS.
    Int J Mol Sci; 2019 Nov 10; 20(22):. PubMed ID: 31717694
    [Abstract] [Full Text] [Related]

  • 33. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A, Xiang Y, Si YR, Fan LJ, Li JP, Li H, Guo W, He HX, Liang XJ, Tan Y, Bao LY, Liao XH.
    J Cell Biochem; 2019 Apr 10; 120(4):6542-6554. PubMed ID: 30368881
    [Abstract] [Full Text] [Related]

  • 34. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B, Liu F, Zeng L, Geng L, Ouyang X, Wang K, Huang Q.
    Med Sci Monit; 2018 May 12; 24():3103-3112. PubMed ID: 29752805
    [Abstract] [Full Text] [Related]

  • 35. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
    Zheng Q, Lin Z, Xu J, Lu Y, Meng Q, Wang C, Yang Y, Xin X, Li X, Pu H, Gui X, Li T, Xiong W, Lu D.
    Cell Death Dis; 2018 Feb 15; 9(3):253. PubMed ID: 29449541
    [Abstract] [Full Text] [Related]

  • 36. IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.
    Wen YY, Liu WT, Sun HR, Ge X, Shi ZM, Wang M, Li W, Zhang JY, Liu LZ, Jiang BH.
    Sci Rep; 2017 Nov 21; 7(1):15897. PubMed ID: 29162853
    [Abstract] [Full Text] [Related]

  • 37. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
    Li C, Zhao Z, Zhou Z, Liu R.
    Dig Dis Sci; 2016 Mar 21; 61(3):767-73. PubMed ID: 26500118
    [Abstract] [Full Text] [Related]

  • 38. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR, Tian MX, Yang LX, Lin YL, Jin L, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, He R, Fan J, Shi YH.
    Oncotarget; 2015 Jan 20; 6(2):846-61. PubMed ID: 25514599
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.